Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

S.A.J. Timmer; T. Germans; W.P Brouwer; J.M. Lubberink; J. van der Velden; A.A.M. Wilde; I. Christiaans; A.A. Lammertsma; P. Knaapen; A.C. van Rossum

doi:10.1093/eurjhf/hfr135

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

S.A.J. Timmer, T. Germans, W.P Brouwer, J.M. Lubberink, J. van der Velden, A.A.M. Wilde, I. Christiaans, A.A. Lammertsma, P. Knaapen, A.C. van Rossum

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1283-1289
Journal	European Journal of Heart Failure
Volume	13
Issue number	12
DOIs	https://doi.org/10.1093/eurjhf/hfr135
Publication status	Published - 2011

Access to Document

10.1093/eurjhf/hfr135

Cite this

Timmer, S. A. J., Germans, T., Brouwer, W. P., Lubberink, J. M., van der Velden, J., Wilde, A. A. M., Christiaans, I., Lammertsma, A. A., Knaapen, P., & van Rossum, A. C. (2011). Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. European Journal of Heart Failure, 13(12), 1283-1289. https://doi.org/10.1093/eurjhf/hfr135

Timmer, S.A.J. ; Germans, T. ; Brouwer, W.P ; Lubberink, J.M. ; van der Velden, J. ; Wilde, A.A.M. ; Christiaans, I. ; Lammertsma, A.A. ; Knaapen, P. ; van Rossum, A.C. / Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. In: European Journal of Heart Failure. 2011 ; Vol. 13, No. 12. pp. 1283-1289.

@article{a9993eab8eba447bbe8d2d66dbcf8e34,

title = "Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction",

author = "S.A.J. Timmer and T. Germans and W.P Brouwer and J.M. Lubberink and {van der Velden}, J. and A.A.M. Wilde and I. Christiaans and A.A. Lammertsma and P. Knaapen and {van Rossum}, A.C.",

year = "2011",

doi = "10.1093/eurjhf/hfr135",

language = "Undefined/Unknown",

volume = "13",

pages = "1283--1289",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley-Blackwell",

number = "12",

}

Timmer, SAJ, Germans, T, Brouwer, WP, Lubberink, JM, van der Velden, J, Wilde, AAM, Christiaans, I, Lammertsma, AA , Knaapen, P & van Rossum, AC 2011, 'Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction', European Journal of Heart Failure, vol. 13, no. 12, pp. 1283-1289. https://doi.org/10.1093/eurjhf/hfr135

Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. / Timmer, S.A.J.; Germans, T.; Brouwer, W.P; Lubberink, J.M.; van der Velden, J.; Wilde, A.A.M.; Christiaans, I.; Lammertsma, A.A.; Knaapen, P.; van Rossum, A.C.

In: European Journal of Heart Failure, Vol. 13, No. 12, 2011, p. 1283-1289.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction

AU - Timmer, S.A.J.

AU - Germans, T.

AU - Brouwer, W.P

AU - Lubberink, J.M.

AU - van der Velden, J.

AU - Wilde, A.A.M.

AU - Christiaans, I.

AU - Lammertsma, A.A.

AU - Knaapen, P.

AU - van Rossum, A.C.

PY - 2011

Y1 - 2011

U2 - 10.1093/eurjhf/hfr135

DO - 10.1093/eurjhf/hfr135

M3 - Article

C2 - 22021246

VL - 13

SP - 1283

EP - 1289

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 12

ER -